öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£º·®½¨»Û
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º39

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£º»ù´¡Ò½Ñ§Ôº
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º Ö×ÁöÉúÎïѧ
Ñо¿ÁìÓò£º Ö×ÁöÉúÎïѧ [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºfanjh@dlmedu.edu.cn


¸öÈ˼òÊö :
·®½¨»Û£¬1979Äê³öÉú£¬²©Ê¿£¬¸±½ÌÊÚ£¬Ë¶Ê¿Éúµ¼Ê¦¡£Ö÷Òª´ÓÊÂÖ×ÁöÉúÎïѧÑо¿£¬½ü5Äê·¢±í¹ú¼ÊÆÚ¿¯ÂÛÎÄ£¨SCIÊÕ¼£©17ƪ£»Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿1Ï**£©£»×÷ΪÖ÷ÒªÍê³ÉÈ˲ÎÓë¿Æ¼¼²¿¹ú¼ÒÖØ´ó»ù´¡Ñо¿¼Æ»®£¨973¼Æ»®£©1Ï2012CB822103£©£¬²ÎÓë¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¼°¸ßµÈѧУ²©Ê¿Ñ§¿ÆµãרÏî¿ÆÑлù½ðÏîÄ¿4Ï2011Äê10Ô£¬ÊÜÑû²Î¼Ó¡°ÈÕ±¾°©Ö¢Ð­»áµÚÆßÊ®½ìÄê»á¡±£¬²¢×÷¿ÚÍ·±¨¸æ£»2011Äê7Ô»ñµÃµÚÊ®½ì¡°ÌôÕ½±­¡±ÁÉÄþÊ¡´óѧÉú¿ÎÍâѧÊõ¿Æ¼¼×÷Æ·¾ºÈüÓÅ ÐãÖ¸µ¼½Ìʦ£»2015ÄêÖÁ½ñÈÎÖйúÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ»áÇàÄê½ÌѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ÈÎίԱ£»²Î±à½Ì²Ä6²¿£¨¸±Ö÷±à1²¿£©£¬²Î±à¡¢²ÎÒëרÖø2²¿¡£

¿ÆÑй¤×÷ :
Ö÷ҪѧÊõÈÎÖ° £º
ÖйúÉúÎﻯѧÓë·Ö×ÓÉúÎïѧѧ»á »áÔ±
ÖйúÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ»á ÇàÄê½ÌѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á ¸±Ö÷ÈÎίԱ
³Ðµ£µÄ¹ú¼Ò¼¶ÏîÄ¿£º£¨½ü5Ä꣩
1. ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬¡°GnT-¢õµÄ±í´ï¼°×ªÔ˵°°×N-ÌÇ»ù»¯¶Ô°òë×°©¼ªÎ÷Ëû±õ»¯ÁÆÃô¸ÐÐÔµÄÓ°Ïì(**)¡°£¬2015.1.1-2017.12.31£»ÏîÄ¿¸ºÔðÈË¡£
2. ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬¡°Caveolin-1µ÷¿ØСÊó¸Î°©Ï¸°û±íÃæ£á2,6-ÍÙÒºËữÓëÖ×ÁöÕ³¸½£¨**£©¡±£¬2011.01-2013.12£¬µÚÈýÍê³ÉÈË
3. ¹ú¼ÒÖØ´ó»ù´¡Ñо¿¼Æ»®£¨973¼Æ»®£©£¬¡°Ö×ÁöµÄÌÇ»¯Ñ§ÉúÎïѧǰÑØÎÊÌâ--ÌÇÁ´¶ÔÖ×Áöϸ°ûÉúÎïѧÐÐΪµÄÓ°Ïì¼°»úÖÆÑо¿£¨2012CB822103£©¡±£¬2012.8-2016.8£¬Ö÷ҪѧÊõ¹Ç¸É
´ú±íÐÔÂÛÎÄ£¨½ü5Ä꣩£º
1. Tang Y, Liu P, Tian Y, Xu Y, Ren F, Cui X, Fan J*. Overexpression of ribonuclease inhibitor defines good prognosis and suppresses proliferation and metastasis in human colorectal cancer cells via PI3K/AKT pathway. Clin Transl Oncol (2.077). 2015, 17(4):306-313.
2. Jianhui Fan, Ying Tang, Jingna He, Shujing Wang, Lifen Wang, Jianing Zhang*Silencing of GnT-V Potentiates the Antitumor Activity of Gemcitabine against Bladder Cancer Cells. Glycoconj J (1.948). 2013, 30: 423.
3. Fan J., Wang S., Yu S., He J., Zheng W., Zhang J.*. N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147. Glycoconj J (1.882). 2012, 29(5-6), 323-334.

½ÌÓý±³¾° :
2009.9-2012.12£¬´óÁ¬Ò½¿Æ´óѧ£¬ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬²©Ê¿£»2003.9-2006.7£¬´óÁ¬Ò½¿Æ´óѧ£¬ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬Ë¶Ê¿£»1998.9¨C2003.7£¬³ÐµÂҽѧԺ£¬ÁÙ´²Ò½Ñ§öλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬Ò½Ñ§Ñ§Ê¿¡£